Trends in survival for patients with esophageal cancer in Japan, 2000–14 (CONCORD-3)
- 20 March 2026
- journal article
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 56 (Supplement) , i17-i24
Abstract
Background: We assessed trends and international comparisons of net survival for patients with esophageal cancer using data from Japanese regional population-based cancer registries participating in the CONCORD-3 study. Methods: The analysis included 63 631 patients aged 15–99 years diagnosed with esophageal cancer during 2000–14, with follow-up completed either 5 years after diagnosis or by 31 December 2014. Five-year net survival was estimated using the Pohar Perme estimator, by sex, anatomical subsite, calendar period of diagnosis, and extent of disease. Survival estimates were age-standardized using the International Cancer Survival Standard weights. Results: During 2000–14, the age-standardized 5-year net survival for esophageal cancer improved from 27.7% (95% CI: 26.4%–29.0%) in 2000–04 to 36.0% (34.8%–37.3%) in 2010–14. This increase corresponded with a higher proportion of patients with localized disease. In 2010–14, survival was notably higher among women, at 42.6% (39.7%–45.5%), than among men, at 36.0% (34.8%–37.3%), and among patients aged 45–54 years at 39.7% (35.5%–44.0%), 55–64 years at 38.9% (37.0%–40.8%), and 65–74 years at 39.4% (37.8%–41.1%). Survival remained lower among the oldest patients, aged 75–99 years, at 29.0% (27.0%–31.0%). By anatomical subsite, survival was highest for the “abdominal, or lower third” segment of the esophagus, followed by the “thoracic, or middle third,” while the “cervical, or upper third” showed the lowest survival. Conclusion: Survival for esophageal cancer in Japan has improved, largely attributable to early detection. Variations by sex, age, and subsite were evident. Detailed analyses using population-based registry data will provide evidence to aid the development of effective cancer control strategies.Keywords
Funding Information
- Japanese Ministry of Health, Labour and Welfare (Cancer Control-General-23EA1033)
This publication has 15 references indexed in Scilit:
- Cancer screening programs in Japan: Progress and challengesJournal of Medical Screening, 2024
- Worldwide trends in esophageal cancer survival, by sub‐site, morphology, and sex: an analysis of 696,974 adults diagnosed in 60 countries during 2000‐2014 (CONCORD‐3)Cancer Communications, 2023
- A population-based comparison of patients with metastatic esophagogastric carcinoma between Japan and the NetherlandsJournal of Cancer Research and Clinical Oncology, 2023
- Management of elderly patients with esophageal squamous cell cancerJapanese Journal of Clinical Oncology, 2022
- Recent progress in perioperative management of patients undergoing esophagectomy for esophageal cancerEsophagus, 2018
- Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countriesThe Lancet, 2018
- Duration of Smoking Cessation and Postoperative Morbidity After Esophagectomy for Esophageal Cancer: How Long Should Patients Stop Smoking Before Surgery?World Journal of Surgery, 2015
- Net Survival Estimation with StnsThe Stata Journal: Promoting communications on statistics and Stata, 2014
- On Estimation in Relative SurvivalBiometrics, 2011
- Standard cancer patient population for age standardising survival ratiosEuropean Journal of Cancer, 2004